Lipocine Inc.

LPCN Stock Healthcare Biotechnology
$1.56
-0.12 (-7.14%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-29.7%
3 Months
-27.4%
YTD
-80.6%
1 Year
-49.8%
3 Year annualized
-17.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
109.6%
Largest decline max drawdown, since Oct 2021
-95.0%
Risk-adjusted return Sharpe ratio, 1-year
0.29

Own LPCN?

See how LPCN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.